Log In
BCIQ
Print this Print this
 

Hepatoren, ifetroban

  Manage Alerts
Collapse Summary General Information
Company Cumberland Pharmaceuticals Inc.
DescriptionInjectable thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor antagonist
Molecular Target Thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor
Mechanism of ActionThromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationLiver disease
Indication DetailsTreat hepatorenal syndrome (HRS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/25/2011

0

0

0

Get a free BioCentury trial today